| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 81, 180-183, Copyright © 1996 by Endocrine Society
ARTICLES |
J Kato, K Kobayashi, T Etoh, M Tanaka, K Kitamura, T Imamura, Y Koiwaya, K Kangawa and T Eto
First Department of Internal Medicine, Miyazaki Medical College, Japan.
We measured plasma concentrations of adrenomedullin (AM), a novel bioactive peptide with potent vasodilator activity, in 21 patients with chronic congestive heart failure due to various heart diseases and compared them to levels in age- and sex-matched healthy subjects to examine the pathophysiological role of plasma AM in heart failure. In addition, the relationship between plasma AM and other hormones known to control the cardiovascular system was examined in these patients. The plasma AM level in the patients with heart failure was significantly (P < 0.01) higher than that in the control subjects (mean +/- SEM, 2.94 +/- 0.15 fmol/mL; n = 16), with a significantly (P < 0.05) higher concentration in patients in class III or IV (11.82 +/- 1.81 fmol/mL; n = 5) of the New York Heart Association functional classification than in those in class I or II (8.74 +/- 0.44 fmol/mL; n = 16). There were no significant correlations between plasma AM and catecholamine levels, whereas the plasma AM level was significantly correlated with the concentrations of plasma atrial natriuretic peptide (r = 0.58; P < 0.01), brain natriuretic peptide (r = 0.47; P < 0.05), and PRA (r = 0.77; P < 0.01) in the patients. Thus, the plasma AM concentration increased in proportion to the severity of heart failure along with the hormones known to modulate the development of congestive heart failure. The present findings suggest a possible role for AM as a circulating hormone participating in the defense mechanism against further deterioration of congestive heart failure in patients with heart disease.
This article has been cited by other articles:
 |
|
 |
|
  E. Braunwald Biomarkers in Heart Failure N. Engl. J. Med., May 15, 2008; 358(20): 2148 - 2159. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Q. Khan, R. J. O'Brien, J. Struck, P. Quinn, N. Morgenthaler, I. Squire, J. Davies, A. Bergmann, and L. L. Ng Prognostic Value of Midregional Pro-Adrenomedullin in Patients With Acute Myocardial Infarction: The LAMP (Leicester Acute Myocardial Infarction Peptide) Study J. Am. Coll. Cardiol., April 10, 2007; 49(14): 1525 - 1532. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. J Pearson, C. Rait, M G. Nicholls, T. G Yandle, and J. J Evans Regulation of adrenomedullin release from human endothelial cells by sex steroids and angiotensin-II. J. Endocrinol., October 1, 2006; 191(1): 171 - 177. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Fujisawa, Y. Nagai, A. Miyatake, K. Miura, T. Shokoji, A. Nishiyama, S. Kimura, and Y. Abe Roles of adrenomedullin 2 in regulating the cardiovascular and sympathetic nervous systems in conscious rats Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H1120 - H1127. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. D. Brain and A. D. Grant Vascular Actions of Calcitonin Gene-Related Peptide and Adrenomedullin Physiol Rev, July 1, 2004; 84(3): 903 - 934. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. M.C. Dixon A new altruist on the block: effects of adrenomedullin after myocardial infarction Cardiovasc Res, December 1, 2002; 56(3): 347 - 349. [Full Text] [PDF]
|
|
|
|
|
|
R. Nakamura, J. Kato, K. Kitamura, H. Onitsuka, T. Imamura, K. Marutsuka, Y. Asada, K. Kangawa, and T. Eto Beneficial effects of adrenomedullin on left ventricular remodeling after myocardial infarction in rats Cardiovasc Res, December 1, 2002; 56(3): 373 - 380. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Zhou, Z. F. Ba, I. H. Chaudry, and P. Wang Adrenomedullin binding protein-1 modulates vascular responsiveness to adrenomedullin in late sepsis Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2002; 283(3): R553 - R560. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C-M Yu, B M Y Cheung, R Leung, Q Wang, W-H Lai, and C-P Lau Increase in plasma adrenomedullin in patients with heart failure characterised by diastolic dysfunction Heart, August 1, 2001; 86(2): 155 - 160. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Zhou, I. H. Chaudry, and P. Wang The small intestine is an important source of adrenomedullin release during polymicrobial sepsis Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2001; 281(2): R654 - R660. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J Autelitano, R. Ridings, and F. Tang Adrenomedullin is a regulated modulator of neonatal cardiomyocyte hypertrophy in vitro Cardiovasc Res, August 1, 2001; 51(2): 255 - 264. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Richards, R. Doughty, M. G. Nicholls, S. MacMahon, N. Sharpe, J. Murphy, E. A. Espiner, C. Frampton, T. G. Yandle, and for the Australia-New Zealand Heart Failure Group Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: Prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction J. Am. Coll. Cardiol., June 1, 2001; 37(7): 1781 - 1787. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Jougasaki and J. C Burnett Jr. Continuing insights into the heart as an endocrine organ: adrenomedullin and cardiac fibroblasts Cardiovasc Res, March 1, 2001; 49(4): 695 - 696. [Full Text] [PDF]
|
|
|
|
|
|
J. G. Lainchbury, D. M. Meyer, M. Jougasaki, J. C. Burnett Jr., and M. M. Redfield Effects of adrenomedullin on load and myocardial performance in normal and heart-failure dogs Am J Physiol Heart Circ Physiol, September 1, 2000; 279(3): H1000 - H1006. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Piquard, A. Charloux, B. Mettauer, E. Epailly, E. Lonsdorfer, S. Popescu, J. Lonsdorfer, and B. Geny Exercise-Induced Increase in Circulating Adrenomedullin Is Related to Mean Blood Pressure in Heart Transplant Recipients J. Clin. Endocrinol. Metab., August 1, 2000; 85(8): 2828 - 2831. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. Rossler, Z. Laszlo, B. Haditsch, and H. G. Hinghofer-Szalkay Orthostatic Stimuli Rapidly Change Plasma Adrenomedullin in Humans Hypertension, November 1, 1999; 34(5): 1147 - 1151. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Ohta, T. Tsuji, S. Asai, K. Sasakura, H. Teraoka, K. Kitamura, and K. Kangawa One-Step Direct Assay for Mature-type Adrenomedullin with Monoclonal Antibodies Clin. Chem., February 1, 1999; 45(2): 244 - 251. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Iwasaki, S. Eguchi, M. Shichiri, F. Marumo, and Y. Hirata Adrenomedullin as a Novel Growth-Promoting Factor for Cultured Vascular Smooth Muscle Cells: Role of Tyrosine Kinase-Mediated Mitogen-Activated Protein Kinase Activation Endocrinology, August 1, 1998; 139(8): 3432 - 3441. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Cormier-Regard, S. V. Nguyen, and W. C. Claycomb Adrenomedullin Gene Expression Is Developmentally Regulated and Induced by Hypoxia in Rat Ventricular Cardiac Myocytes J. Biol. Chem., July 10, 1998; 273(28): 17787 - 17792. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Richards, M. G. Nicholls, T. G. Yandle, C. Frampton, E. A. Espiner, J. G. Turner, R. C. Buttimore, J. G. Lainchbury, J. M. Elliott, H. Ikram, et al. Plasma N-Terminal Pro–Brain Natriuretic Peptide and Adrenomedullin : New Neurohormonal Predictors of Left Ventricular Function and Prognosis After Myocardial Infarction Circulation, May 19, 1998; 97(19): 1921 - 1929. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. A. Cameron and A. M. Fleming Novel Sites of Adrenomedullin Gene Expression in Mouse and Rat Tissues Endocrinology, May 1, 1998; 139(5): 2253 - 2264. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. K. Samson, T. C. Murphy, and Z. T. Resch Central mechanisms for the hypertensive effects of preproadrenomedullin-derived peptides in conscious rats Am J Physiol Regulatory Integrative Comp Physiol, May 1, 1998; 274(5): R1505 - R1509. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Szokodi, P. Kinnunen, P. Tavi, M. Weckstrom, M. Toth, and H. Ruskoaho Evidence for cAMP-Independent Mechanisms Mediating the Effects of Adrenomedullin, a New Inotropic Peptide Circulation, March 24, 1998; 97(11): 1062 - 1070. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Nishikimi, S. Nagata, T. Sasaki, S. Tomimoto, H. Matsuoka, S. Takishita, K. Kitamura, A. Miyata, H. Matsuo, and K. Kangawa Plasma concentrations of adrenomedullin correlate with the extent of pulmonary hypertension in patients with mitral stenosis Heart, October 1, 1997; 78(4): 390 - 395. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Rademaker, C. J. Charles, L. K. Lewis, T. G. Yandle, G. J. S. Cooper, D. H. Coy, A. M. Richards, and M. G. Nicholls Beneficial Hemodynamic and Renal Effects of Adrenomedullin in an Ovine Model of Heart Failure Circulation, September 16, 1997; 96(6): 1983 - 1990. [Abstract] [Full Text]
|
|
|
|
|
|
M. Kohno, K. Yokokawa, H. Kano, K. Yasunari, M. Minami, T. Hanehira, and J. Yoshikawa Adrenomedullin Is a Potent Inhibitor of Angiotensin II–Induced Migration of Human Coronary Artery Smooth Muscle Cells Hypertension, June 1, 1997; 29(6): 1309 - 1313. [Abstract] [Full Text]
|
|
|
|
|
|
B. L. Jensen, B. K. Kramer, and A. Kurtz Adrenomedullin Stimulates Renin Release and Renin mRNA in Mouse Juxtaglomerular Granular Cells Hypertension, May 1, 1997; 29(5): 1148 - 1155. [Abstract] [Full Text]
|
|
|
|
|
|
P. G. Andreis, G. Neri, T. Prayer-Galetti, G. P. Rossi, G. Gottardo, L. K. Malendowicz, and G. G. Nussdorfer Effects of Adrenomedullin on the Human Adrenal Glands: An in Vitro Study J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1167 - 1170. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Nakamura, H. Yoshida, S. Makita, N. Arakawa, H. Niinuma, and K. Hiramori Potent and Long-Lasting Vasodilatory Effects of Adrenomedullin in Humans: Comparisons Between Normal Subjects and Patients With Chronic Heart Failure Circulation, March 4, 1997; 95(5): 1214 - 1221. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
